Joint IPVS-ENTOG webinar: Special considerations about women with cervical precancerous lesions

Joint IPVS-ENTOG webinar: Special considerations about women with cervical precancerous lesions

Wednesday, December 11, 2024
16:00-17:30 CET (Geneva) / 10:00-11:30 EST (New York)

Topic:

Join us for a 90-minute in-depth exploration of key concerns surrounding cervical precancerous lesions in women. This webinar will provide valuable insights into the risks, screening strategies, and management options for both patients and their partners. Featuring expert presentations from leading specialists, this session will address the latest research and clinical practices aimed at improving patient outcomes.

WEBINAR AIMS

1.) Estimate the risk of having or developing anal intraepithelial neoplasia for women with cervical precancerous lesions.
2.) Evaluate the updated available options for anal cancer screening among high-risk populations.
3.) Assess the risk of having or developing vulvar intraepithelial neoplasia for women with cervical precancerous lesions.
4.) Review the examination process of the vulva and vagina during a colposcopy session.
5.) Describe the risk of having or acquiring a HPV-related disease for the male partners of women treated for cervical precancerous lesions.
6.) Assess the risk of having or developing vaginal intraepithelial neoplasia for women with cervical precancerous lesions.

FACULTY

1.) Anal intraepithelial neoplasia in women with cervical precancerous lesions – Mayura Nathan, MBBS, FRCP
2.) Vulvar or vaginal intraepithelial neoplasia in women with cervical precancerous lesions – Mario Preti, MD
3.) Consultation regarding HPV-related diseases for the male partners of women with cervical precancerous lesions – Anna Giuliano, PhD

Moderators: Kimon Chatzistamatiou, MD, PhD and Sara Vodopivec, MD

This webinar has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.5 European CME credits (ECMEC®s).